We are currently looking for adults (18 and over) diagnosed with primary IgA Nephropathy to take part in a clinical study.
IgAN is a rare autoimmune disease. In people with IgAN, an uncommon form of the protein IgA1 builds up in the kidneys.
IMAGINATION (WA43966)
is a global clinical study to test a potential new treatment for people with primary IgA nephropathy (IgAN).
The study will assess the effectiveness and safety of RO7434656, also known as sefaxersen, compared to placebo, for treating people with primary IgAN.
Participating Is Easy, Safe, and Worthwhile
Everyone who takes part in the study will receive close monitoring by the local study team.
If you are interested, then the study doctor will describe the study to you, including what the treatments and tests are, and how often you need to attend study visits. They will also answer any questions you have.
If you qualify
and decide to take part, then you will be
asked to attend regular visits for a
minimum of 2 years.
If you are interested in finding out more,
please speak with your study doctor,
or call (470) 227-8130
More information about the IMAGINATION study can be found using the following links: Click Here